The Verification Standard — What Makes a COA Trustworthy

The phrase "Certificate of Analysis" appears on product pages across the research chemicals industry. But the words alone mean nothing. A document labelled COA could be a rigorous, independent analytical report — or it could be a spreadsheet generated in-house by the same company selling the material. The difference between those two things is not a matter of degree. It is the entire difference between verification and the absence of it.

Understanding what separates a trustworthy certificate from a nominal one requires looking at the structure of verification itself. There are four pillars, each addressing a different question a researcher or auditor must answer before any batch can be considered verified. Weakness in any one of them undermines the whole.

Pillar One: Identity Confirmation

The first and most fundamental question is: is this compound actually what the label says it is? Purity measurements alone cannot answer it. A sample can register high purity on an HPLC chromatogram while being composed entirely of the wrong molecule — an analogue, a degradation product, or a structurally similar compound with a different biological profile. Purity describes how much of something is present; it says nothing about what that something is.

Identity confirmation requires mass spectrometry. Liquid Chromatography-Mass Spectrometry (LC-MS) separates compounds by their movement through a chromatographic column and then measures the mass-to-charge ratio of the resulting ions. For a given peptide, the expected molecular weight can be calculated precisely from its amino acid sequence. The instrument reports the found mass — typically expressed as [M+H]⁺ or [M+2H]²⁺ for multiply charged species — and the analyst compares it to the theoretical value.

A trustworthy COA does not merely state that LC-MS was performed. It includes the mass spectrum so that the match between found and expected mass is visible and independently checkable. A bare assertion of identity, with no spectrum attached, is not evidence of identity. It is a claim.

Pillar Two: Purity Evidence

Purity is the proportion of the sample that consists of the target compound. In practice, any batch of synthesised peptide will contain some level of by-products, truncated sequences, protecting-group residues, and other impurities from the synthesis process. The purity figure reports how much of the material is the correct, full-length peptide.

The standard method for measuring peptide purity in this context is High-Performance Liquid Chromatography (HPLC). The sample is dissolved and passed through a column under pressure, with different compounds eluting at different times based on their interaction with the stationary phase. A UV detector records the absorbance as each fraction passes, producing a chromatogram: a series of peaks over time. The area under each peak, expressed as a proportion of total peak area, gives the purity figure for that component.

For research-grade material, purity is commonly assessed against a benchmark of ≥98% by HPLC. Batches below this threshold may still be useful for some purposes, but the figure matters because it is a direct statement of composition. A batch at 85% purity contains 15% of other material — and that other material is usually uncharacterised without further analysis.

What distinguishes a trustworthy purity report is the presence of the chromatogram itself. The attached chart shows the analyst and reviewer exactly how the peaks were integrated, whether the baseline was stable, and whether any shoulders or unresolved peaks were present. Without the chromatogram, a purity percentage is an unverifiable number.

Pillar Three: Contaminant Screening

A compound can pass identity and purity checks while still presenting problems that are invisible to HPLC and LC-MS. Two contaminants that a complete COA should address are residual water and bacterial endotoxins.

Water Content — Karl Fischer Titration

Lyophilised (freeze-dried) peptides always contain some residual water. This matters for two reasons. First, water content affects the true mass of peptide in a given weighed sample. If a vial contains 10 mg of material but 8% of that mass is water, the actual peptide content is closer to 9.2 mg — a difference that becomes significant when calculating research concentrations. Second, high residual moisture accelerates degradation over storage.

The standard method for measuring water content in pharmaceutical and research materials is Karl Fischer (KF) titration, a well-validated coulometric or volumetric technique referenced in the United States Pharmacopeia (USP) under general chapter <921> and equivalent monographs in the European Pharmacopoeia. A trustworthy COA states the water content as a percentage of total mass, with the method noted.

Endotoxin — Limulus Amebocyte Lysate (LAL) Testing

Bacterial endotoxins are lipopolysaccharides (LPS) found in the outer membrane of gram-negative bacteria. In cell culture or in vivo research contexts, endotoxin contamination can produce strong inflammatory responses that confound experimental results. Because endotoxins are heat-stable and are not destroyed by standard sterilisation methods, they must be measured directly.

The reference test is the Limulus Amebocyte Lysate (LAL) assay, which detects endotoxin by its ability to clot the blood lysate of the horseshoe crab. Results are expressed in Endotoxin Units per milligram (EU/mg). Regulatory limits vary by application — pharmaceutical parenteral preparations are held to very tight thresholds — but any COA used for in vitro or in vivo research should state the endotoxin level so researchers can assess suitability for their specific work. The absence of this figure does not mean the batch is endotoxin-free; it means the batch was not tested, or the result was not disclosed.

Pillar Four: Chain of Custody

Even a perfectly executed analytical report can be misrepresented or recycled. The fourth pillar addresses the integrity of the document itself: the trail from synthesis to the certificate in the researcher's hands must be traceable without ambiguity.

Chain of custody in this context involves several concrete elements. The lot number is the most important: the COA must reference the same lot number that appears on the vial being supplied. A certificate for Lot 2023-A accompanying Lot 2024-C material is not verification of that material — it is the record of a different batch.

The analysis date should be contemporary with the manufacture and dispatch of the batch, not recycled from a previous run. The analyst who performed the testing should be named and their signature or stamp present, creating accountability. The issuing laboratory should be identifiable: a name, a physical address, and — ideally — a verifiable accreditation number.

This last point connects to a deeper principle. A certificate can be technically detailed and still lack independent force if the issuing body is not independent of the seller. An in-house quality control document produced by the vendor's own laboratory is not a third-party COA. The conflict of interest is structural: the seller is grading its own work, with no external check on the result. Genuine verification requires an independent issuer — one with no commercial stake in the outcome of the analysis.

Why All Four Pillars Are Required

The four pillars — identity, purity, contaminants, and chain of custody — are not independent options. They address different failure modes, and the absence of any one leaves a gap that the others cannot close.

A batch verified against all four pillars gives a researcher a clear picture of what they are working with: a specific molecule, at a stated purity, with known contaminant levels, documented by an independent party for this specific lot. That is the verification standard. Anything short of it is an incomplete record.

The Role of the Issuing Laboratory

Running through all four pillars is a common thread: the independence and competence of the entity that performed the testing. Analytical results are only as reliable as the laboratory and the methods behind them. A well-run, accredited independent laboratory uses validated methods, participates in proficiency testing, and operates under a quality management system designed to produce reproducible results. These are not incidental features — they are what make the numbers on a COA meaningful rather than arbitrary.

The international standard for the competence of testing and calibration laboratories is ISO/IEC 17025. Accreditation under this standard, granted by a recognised national body, provides an external check on a laboratory's systems and methods. When a COA is issued by an ISO/IEC 17025-accredited laboratory and references an accreditation number that can be verified, each of the four pillars is supported by a quality infrastructure built specifically to ensure their reliability.

Understanding what that accreditation means — how it is obtained, what it covers, and how to confirm it — is the subject of a separate article in this registry. For the purposes of the verification standard: the issuing laboratory's credentials are not a footnote. They are the foundation on which everything else rests.

Applying the Standard

In practice, applying the verification standard begins before a purchase decision is made. A researcher or auditor reviewing a COA should work through each pillar in sequence. Does the certificate confirm identity by LC-MS, with a spectrum? Does it report HPLC purity with a chromatogram? Does it state water content and endotoxin? Does the lot number match the vial, and was the certificate issued by a named, independent laboratory?

If the answer to any of these questions is no, the COA is incomplete. An incomplete COA cannot verify the batch, regardless of how it is presented. The appropriate response is to request the missing documentation, or to treat the batch as unverified until it is provided.

The standard is not flexible because the gaps it guards against are not minor. An unconfirmed identity is a compound of unknown nature. An unscreened endotoxin level is an unknown biological variable. A recycled lot number is, in effect, no record at all. The verification standard exists because each of these gaps carries real consequences for anyone using these materials in research.

References: United States Pharmacopeia (USP) — general chapters on HPLC, KF water determination, and LAL endotoxin testing; WHO quality principles for pharmaceutical substances; ISO/IEC 17025:2017 general requirements for testing laboratory competence. Updated July 2026.